These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21372412)

  • 1. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.
    Xia XJ; Guo RF; Liu YL; Zhang PX; Zhou CP; Jin DJ; Wang RY
    Chem Pharm Bull (Tokyo); 2011; 59(3):321-6. PubMed ID: 21372412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
    Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.
    Fan T; Takayama K; Hattori Y; Maitani Y
    Pharm Res; 2004 Sep; 21(9):1692-7. PubMed ID: 15497698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability.
    Han J; Davis SS; Papandreou C; Melia CD; Washington C
    Pharm Res; 2004 Sep; 21(9):1573-80. PubMed ID: 15497682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
    Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
    Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.
    Kadam AN; Najlah M; Wan KW; Ahmed W; Crean SJ; Phoenix DA; Taylor KM; Elhissi AM
    Pharm Dev Technol; 2014 Dec; 19(8):999-1004. PubMed ID: 24093888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol.
    Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y
    Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system.
    Kan P; Chen ZB; Lee CJ; Chu IM
    J Control Release; 1999 Apr; 58(3):271-8. PubMed ID: 10099152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
    Najlah M; Kadam A; Wan KW; Ahmed W; Taylor KM; Elhissi AM
    Int J Pharm; 2016 Jun; 506(1-2):102-9. PubMed ID: 27107899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions.
    Kim JE; Park YJ
    Colloids Surf B Biointerfaces; 2017 Feb; 150():362-372. PubMed ID: 27823852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization.
    Li Y; Zhao X; Zu Y; Zhang Y
    Int J Pharm; 2015 Jul; 490(1-2):324-33. PubMed ID: 26027492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers.
    Mu L; Feng SS
    J Control Release; 2001 Oct; 76(3):239-54. PubMed ID: 11578739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative formulations of paclitaxel.
    Terwogt JM; Nuijen B; Huinink WW; Beijnen JH
    Cancer Treat Rev; 1997 Mar; 23(2):87-95. PubMed ID: 9225960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution.
    Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q
    Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
    Liang H; Yang Q; Deng L; Lu J; Chen J
    Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.
    Zhang HY; Tang X; Li HY; Liu XL
    Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionically fixed polymeric nanoparticles as a novel drug carrier.
    Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
    Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.